Company News
Natco Pharma Increases eGenesis Investment to $16.7M
Natco Pharma increases investment in eGenesis from $14M to $16.7M through convertible notes via subsidiaries.
Investment structure changes with $13.7M from Natco Canada and $3M from Natco USA LLC.
Tot
